Rush Medical College is a clinical research site located in Chicago, Illinois, United States 60612-3828.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Rush Medical College has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Small Cell Lung Cancer, Angelman Syndrome, Chromosome 15q Duplication (dup15q) Syndrome.
Sponsors: Poniard Pharmaceuticals, Biogen, Human Genome Sciences Inc..
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rush Medical College has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush Medical College has 5 clinical trials on record, with 1 currently active. Their work covers Small Cell Lung Cancer, Angelman Syndrome, Chromosome 15q Duplication (dup15q) Syndrome.
Yes — Rush Medical College holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.